Sabril® ( DrugBank: - )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
145	ウエスト症候群	2

145. ウエスト症候群

---

臨床試験数 : 43 /  薬物数 : 54 - (DrugBank : 15) / 標的遺伝子数 : 27 - 標的パスウェイ数 : 24

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02220114 (ClinicalTrials.gov)	May 2014	14/8/2014	Acceptability Study of a New Paediatric Form of Vigabatrin in Infants and Children With Infantile Spasms or Pharmacoresistant Partial Epilepsy	Acceptability Study of a New Paediatric Form of Vigabatrin in Infants and Children With Infantile Spasms or Pharmacoresistant Partial Epilepsy. Observational, Descriptive, Open-label, Multi-centric, Non-randomized Study	Infantile Spasms	Drug: Vigabatrin: Vigabatrin new ST formulation then Sabril®	Orphelia Pharma	Institut National de la Santé Et de la Recherche Médicale, France;Hospices Civils de Lyon;National Research Agency, France	Completed	1 Month	6 Years	All	38	N/A	France
2	NCT01073579 (ClinicalTrials.gov)	August 2009	22/2/2010	Sabril Patient Registry	Sabril Patient Registry	Infantile Spasms;Refractory Complex Partial Seizures in Adults	Drug: Sabril®	Lundbeck LLC	NULL	Completed	N/A	N/A	Both	9423	N/A	NULL